Jeffrey J. Tomaszewski, MD, and David Y.T. Chen, MD
All articles by Jeffrey J. Tomaszewski, MD, and David Y.T. Chen, MD
Innovative approaches offer the potential for effective treatments to limited target
areas with improved side effect profiles.
Radical cystectomy with urinary diversion including neobladder remains the standard of care for muscle-invasive bladder cancer.
Next post in On The Forefront